一种AAV基因疗法整合多种细胞输入实现对小鼠多灶性肝细胞癌的精准靶向
研究开发了一种基于腺相关病毒(AAV)载体的生物分子多输入逻辑模块设计方法,构建的原型基因疗法在系统给药后,通过计算肿瘤与非肿瘤细胞转录及microRNA输入的差异,驱动单纯疱疹病毒胸苷激酶(HSV-TK)效应基因在肿瘤细胞中特异性表达。在 orthotopic 小鼠肿瘤模型中,静脉注射载体联合更昔洛韦使治疗组小鼠肿瘤负荷较对照组显著降低,且未对一般健康状况或体重产生不良影响。
要点
- AAV编码的多输入逻辑模块可整合转录与microRNA输入,精准区分肿瘤与非肿瘤细胞。
- 系统给药联合更昔洛韦使小鼠肿瘤负荷较对照组显著降低,未影响一般状况或体重。
- 细胞水平的多输入运算是驱动体内肿瘤特异性HSV-TK表达所必需且充分的。
核心结论
- 该疗法能对患病与健康细胞特异性分子输入进行逻辑整合以精准调控效应基因表达,作者认为其是下一代癌症疗法的有前景途径。
研究设计与样本
- 研究开发了基于AAV载体的生物分子多输入逻辑模块设计方法,并构建了编码HSV-TK效应基因的原型基因疗法。
- 在 orthotopic 小鼠肿瘤模型中经系统给药评估该疗法的抗肿瘤效果。
主要发现
- 治疗组小鼠经静脉注射载体联合更昔洛韦后,肿瘤负荷较对照组显著降低。
- 治疗组小鼠一般健康状况或体重未出现不良影响。
- HSV-TK在肿瘤中特异性表达,在非肿瘤肝脏及其他器官中伴随表达极少。
- 单个细胞内的多输入运算对驱动体内原位肿瘤特异性HSV-TK表达是必要且充分的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical translation of multi-input biomolecular computing systems holds potential to lead to disease-tailored, data-driven rational design of next-generation therapeutic modalities. However, practical demonstrations of this potential are lacking. Here, we developed a clinically translatable approach for the design and implementation of therapeutic agents comprising biomolecular multi-input logic modules for precision cell targeting, compatible with adeno-associated virus (AAV) vectors. We used this approach to engineer an AAV-encoded gene therapy prototype that, when delivered systemically, successfully treated hepatocellular carcinoma in an orthotopic mouse tumor model. The therapy performed a molecular-scale computation over multiple transcriptional and microRNA inputs based on the differential molecular profiles of tumor and nontumor cells, to guide the activation of a herpes simplex virus thymidine kinase (HSV-TK) effector gene. Multi-input computation in individual cells was necessary and sufficient to drive in vivo and in situ tumor-specific expression of HSV-TK with minimal concomitant expression in nontumor liver and other organs. Intravenous vector injection in combination with ganciclovir resulted in marked reduction in tumor burden in treated mice compared with controls, without negative effects on general well-being or weight. The therapeutic approach has the capacity to perform logical integration of diseased and healthy cell–specific molecular inputs to precisely regulate therapeutic effector gene expression and is a promising avenue for the next generation of cancer therapies. Moreover, our systematic data-driven workflow illustrates how gene expression data can shape the molecular composition of future therapeutic candidates.
引用
- Angelici B, Shen L, Schreiber J, et al. An AAV gene therapy computes over multiple cellular inputs to enable precise targeting of multifocal hepatocellular carcinoma in mice. Sci Transl Med. 2021. PMID: 34910545. doi:10.1126/scitranslmed.abh4456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。